Mark Baxter

Yeah, and can allow them to have these kind of imaginal or symbolic experiences

of deeply meaningful experiences that can give them just a whole new perspective on their life or their challenges as well.

And so there's a little bit of talk therapy component there, but mostly it's kind of people going through an inner process of that.

So they look very different sometimes.

Yeah.

Well, people come with all their habits, their protectors, their coping skills, their lenses, their...

Everything.

Their armour, right?

And the armour's there for a reason.

So they come into the therapy room in a normal therapy session and you're kind of working with their armour as much as you're trying to work with kind of healing some pain or to see different perspectives.

But lots of armour work, whereas these substances can really change a person's ability to relax the armour and to get into some of the stuff that's around underneath all of that.

So that's where they can be really helpful.

Yeah, this is the long-lasting thing is where I'm really interested in.

That's a great question.

We don't have good information yet.

So just for the NDMA-assisted therapy for PTSD, so the main results come out of clinical trials run by MAPS in America and the Multidisciplinary Association for Psychedelic Studies.

So they've done a bunch of phase two and phase three clinical trials.

In their results, about two-thirds of people are coming out as kind of not having, not meeting the qualification for PTSD anymore.

So what we would see is PTSD-free symptomatically.

You know, a further third are having some benefit but still, you know, meeting the criteria for PTSD.